Specificity Testing in Bioanalytical Assay Validations—Challenges and Opportunities
Biomedical Chromatography · 2026-12 · 40 (12)
DOI: 10.1002/bmc.70643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomedical Chromatography, online erschienen am 19.10.2026. Verfasst von Raja Reddy Kallem und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacology and Pharmacometrics, Lundbeck Pharmaceuticals LLC, Deerfield, Illinois, USA. Hauptthemen laut MEDLINE: Liquid Chromatography-Mass Spectrometry, Tandem Mass Spectrometry. Die Arbeit nennt 17 Literaturangaben.
Abstract (Originalsprache)
Specificity assessment is essential in bioanalytical method development to ensure accurate analyte quantification in the presence of endogenous matrix components and potential exogenous interferences. Regulatory expectations have evolved over time, culminating in the harmonized ICH M10 guideline, which establishes a globally aligned framework for bioanalytical method validation. Although LC–MS/MS provides high analytical specificity, challenges remain, particularly from isobaric interferences and increasingly complex multi‐analyte assays. A common practical issue is trace contamination of authentic reference standards, such as parent drug in metabolite standards or vice versa, which can generate unacceptable cross‐signal contributions and compromise specificity assessments. When such impurities preclude conventional specificity testing, this perspective discusses scientifically justified approaches, including predetermined baseline corrections to account for contaminated standards. It also highlights incurred sample reanalysis (ISR) as a more meaningful assessment of assay specificity under these constrained conditions because it reflects the true in vivo composition of parent drug and metabolites. The application of ISR has emerged as a robust, regulatory‐endorsed tool for confirming assay reliability over time and, as such, could also serve as an alternative for some of the issues discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacology and Pharmacometrics, Lundbeck Pharmaceuticals LLC, Deerfield, Illinois, USA.
- Department of Pharmaceutical and Biomedical Sciences, College of Pharmacy, University of Georgia, Athens, Georgia, USA.
ORCID-Profile: Raja Reddy Kallem, Michael G Bartlett
Zitieren
APA
Kallem, R. R., Bartlett, M. G., & Srinivas, N. R. (2026). Specificity Testing in Bioanalytical Assay Validations—Challenges and Opportunities. Biomedical Chromatography, 40(12). https://doi.org/10.1002/bmc.70643
Vancouver
Kallem RR, Bartlett MG, Srinivas NR. Specificity Testing in Bioanalytical Assay Validations—Challenges and Opportunities. Biomedical Chromatography. 2026;40(12). doi:10.1002/bmc.70643
BibTeX
@article{Kallem2026,
author = {Kallem, Raja Reddy and Bartlett, Michael G and Srinivas, Nuggehally R},
title = {Specificity Testing in Bioanalytical Assay Validations—Challenges and Opportunities},
journal = {Biomedical Chromatography},
year = {2026},
volume = {40},
number = {12},
doi = {10.1002/bmc.70643}
}
EUVIMED